Related references
Note: Only part of the references are listed.The Pathogenesis of Systemic Sclerosis
Tamiko R. Katsumoto et al.
ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)
Gastroesophageal Reflux Incites Interstitial Lung Disease in Systemic Sclerosis: Clinical, Radiologic, Histopathologic, and Treatment Evidence
Romy B. Christmann et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2010)
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma
Edoardo Savarino et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Prevalence of gastroesophageal reflux disease in patients with idiopathic pulmonary fibrosis
Cristiane Dupont Bandeira et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2009)
Mechanisms of Disease: Scleroderma.
Armando Gabrielli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Consensus Recommendations for Gastric Emptying Scintigraphy: A Joint Report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine
Thomas L. Abell et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough
Inder Mainie et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2008)
Clinical trial:: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis -: a randomized controlled, cross-over trial
P. Janiak et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Esophageal disease in scleroderma
Ellen C. Ebert
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis
G Raghu et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Review article: extraoesophageal manifestations of gastro-oesophageal reflux disease
JE Richter
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Histamine-2 receptor antagonists at night improve gastroesophageal reflux disease symptoms for patients on proton pump inhibitor therapy
A Rackoff et al.
DISEASES OF THE ESOPHAGUS (2005)
Scleroderma epidemiology
MD Mayes
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2003)
Clinical symptoms in endoscopic reflux esophagitis: Evaluation in 8031 adult subjects
K Okamoto et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
Systemic sclerosis sine scleroderma: is it always the same disease? Report of three patients and discussion
G Slobodin et al.
RHEUMATOLOGY INTERNATIONAL (2002)
Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors
S Xue et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2001)
Share Paper
